BR0316059A - Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise - Google Patents

Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise

Info

Publication number
BR0316059A
BR0316059A BR0316059-9A BR0316059A BR0316059A BR 0316059 A BR0316059 A BR 0316059A BR 0316059 A BR0316059 A BR 0316059A BR 0316059 A BR0316059 A BR 0316059A
Authority
BR
Brazil
Prior art keywords
fosinopril
dialysis patients
cardiovascular events
reduce cardiovascular
reduce
Prior art date
Application number
BR0316059-9A
Other languages
English (en)
Inventor
Eric Rougemond
Nadial Amellal
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of BR0316059A publication Critical patent/BR0316059A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)

Abstract

"USO DE FOSINOPRIL PARA REDUZIR EVENTOS CARDIOVASCULARES EM PACIENTES DE DIáLISE". A invenção refere-se ao uso de fosinopril ou um sal farmaceuticamente aceitável do mesmo, para reduzir o risco de ocorrência de um evento cardiovascular em pacientes de diálise, em particular pacientes de diálise sang³ínea, especialmente pacientes apresentando hipertrofia ventricular esquerda.
BR0316059-9A 2002-11-08 2003-10-09 Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise BR0316059A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0214060A FR2846886A1 (fr) 2002-11-08 2002-11-08 Utilisation de fosinopril pour diminuer les evenements cardiovasculaires chez des patients dialyses
PCT/EP2003/011147 WO2004041290A1 (en) 2002-11-08 2003-10-09 Use of fosinopril to reduce cardiovascular events in dialysis patients

Publications (1)

Publication Number Publication Date
BR0316059A true BR0316059A (pt) 2005-09-27

Family

ID=32116508

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0316059-9A BR0316059A (pt) 2002-11-08 2003-10-09 Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise

Country Status (14)

Country Link
US (1) US20060135482A1 (pt)
EP (1) EP1558267A1 (pt)
JP (1) JP2006506405A (pt)
KR (1) KR20050072480A (pt)
CN (1) CN1708308A (pt)
AR (1) AR042000A1 (pt)
AU (1) AU2003278059A1 (pt)
BR (1) BR0316059A (pt)
CA (1) CA2505324A1 (pt)
FR (1) FR2846886A1 (pt)
MX (1) MXPA05004753A (pt)
PL (1) PL374906A1 (pt)
WO (1) WO2004041290A1 (pt)
ZA (1) ZA200504652B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006100602A2 (en) * 2005-03-22 2006-09-28 Aurobindo Pharma Ltd Immediate release stable solid oral dosage forms op fosinopril
CA2570763C (en) * 2005-07-08 2011-08-23 Mochida Pharmaceutical Co., Ltd. Composition for preventing onset of cardiovascular events
US20070087975A1 (en) * 2005-10-17 2007-04-19 Sigma-Tau Industrie Farmaceutiche Riunite Spa Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients
SI23149A (sl) * 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931464A (en) * 1989-02-15 1990-06-05 E. R. Squibb & Sons, Inc. Method of reducing pre- and post-ischemic myocardial arrhythmias and fibrillation
JP2005503378A (ja) * 2001-08-06 2005-02-03 ジエノメツド・エル・エル・シー Ａｃｅの過剰に関連する疾患の治療方法及び組成物
BR0308053A (pt) * 2002-02-28 2004-12-28 Novartis Ag Stents revestidos com n-{5-[4-(4-metil-piperazino-metil)-benzoilamido]-2-metil fenil}-4-(3-piridil)-2-pirimidina-amina

Also Published As

Publication number Publication date
WO2004041290A1 (en) 2004-05-21
AU2003278059A1 (en) 2004-06-07
AR042000A1 (es) 2005-06-08
PL374906A1 (en) 2005-11-14
US20060135482A1 (en) 2006-06-22
CN1708308A (zh) 2005-12-14
EP1558267A1 (en) 2005-08-03
FR2846886A1 (fr) 2004-05-14
MXPA05004753A (es) 2005-08-02
JP2006506405A (ja) 2006-02-23
KR20050072480A (ko) 2005-07-11
CA2505324A1 (en) 2004-05-21
ZA200504652B (en) 2006-03-29

Similar Documents

Publication Publication Date Title
BR0308904A (pt) Método de tratamento de gastroparesia, e, uso de um composto de glp-1
BR9712523A (pt) Novos derivados de pirazol heterociclilmetil-substituìdos
TR200003333T2 (tr) Ensülin direngenliği ve hiperglisemi tedavisinde yararlı benzotiyofenler
EA200101156A1 (ru) ЛЕКАРСТВЕННЫЕ КОМПОЗИЦИИ НОВОГО ТИПА НА ОСНОВЕ ОБЛАДАЮЩИХ ХОЛИНЕРГИЧЕСКИМ ДЕЙСТВИЕМ СОЕДИНЕНИЙ И β-МИМЕТИКОВ
DE69005347D1 (de) Absaugkanüle für chirurgische Zwecke, insbesondere für Fettabsaugung.
CY1109191T1 (el) Μια νεα χρηση της δεφεριπρονης
BR0116519B1 (pt) cartucho de hemodiafiltraÇço/hemofiltraÇço de diluiÇço intermediÁria.
BRPI0409359A (pt) análogos quiméricos de somatostatina-dopamina
BR0013924A (pt) Soluções farmacêuticas de levosimendano
ATE336243T1 (de) Verwendung von l-carnitin und seinen alkanoyl- derivaten als osmotisches mittel in lösungen für medizinische verwendung
BR0011578A (pt) Utilização do s-enantiÈmero de citalopram para tratamento de distúrbio de ansiedade geral ou ataques de pânico
SE9900043D0 (sv) New use
DK1643999T3 (da) Pyridoxamin til anvendelse ved behandlingen af diabetisk nefropati ved type 2-diabetes
CY1105317T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
CY1105142T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
BR9914644A (pt) Composições tamponadas para diálise
DK1305037T3 (da) Smertestillende medikament
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
BR0316059A (pt) Uso de fosinopril para reduzir eventos cardiovasculares em pacientes de diálise
WO2003018535A3 (en) Novel aminobenzoephenones
WO2001060343A3 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
BR0303384A (pt) Citalopram e seus usos no tratamento de pressão sanguìnea elevada
GR1004434B (el) Χρησηατουαdiclofenacαhααποδεκτωνααλατωνααυτουαγιαατηνααντιμετωπισηατωναεγκαυματων
PT1937245E (pt) Composto útil para a prevenção e o tratamento de hipertrofia ventricular esquerda em pacientes dialisados

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]